Cardiovascular Disorders

  • James W. Jefferson
  • John R. Marshall
Part of the Critical Issues in Psychiatry book series (CIPS)


Heart failure is a condition in which the heart is unable to pump enough blood to supply the demands of the body. Although the cardiac output is usually reduced during heart failure, it may also be normal or elevated—the critical factor being that, whatever the output, it is inadequate to meet the metabolic requirements of the body.


Cerebral Blood Flow Sexual Dysfunction Postural Hypotension Giant Cell Arteritis Cardiovascular Disorder 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abdon N-J, Malmcrona R: High pacemaker implantation rate following “Cardiogenic Neurology.” Acta Med Scand 198: 455–461, 1975.PubMedCrossRefGoogle Scholar
  2. Abelson D: Diagnostic value of the penile pulse and blood pressure: A Doppler study of impotence in diabetes. J. Urology 113: 636–639, 1975.Google Scholar
  3. Adams RD, Braunwald E: Faintness, syncope, and episodic weakness, in Wintrobe MW, Thorn GW, Adams RD,(eds): Harrison’s Principles of Internal Medicine, ed. New York, McGraw—Hill, 1974, pp 72–78.Google Scholar
  4. Adler S: Methyldopa-induced decrease in mental activity. JAMA 230: 1428–1429, 1974.PubMedCrossRefGoogle Scholar
  5. Anderson, LG, Bayles TB: Polymyalgia rheumatica and giant cell arteritis. Disease-a-Month, pp 1–36, Jan 1974.Google Scholar
  6. Anonymous: Bypass to raise penile blood said to correct impotence. Med Tribune Mar 10, 1976.Google Scholar
  7. Anonymous: Cardiogenic dementia. Lancet 1:27–28, 1977(a).Google Scholar
  8. Anonymous: New surgical treatment for impotence: Revascularization. Med World News Jan 10, 1977(b), p 26.Google Scholar
  9. Anonymous: Prolapsed mitral leaflet could be most common valve disorder. JAMA 239: 687–688, 1978.CrossRefGoogle Scholar
  10. Antel JJ, Rome HP, Geraci JE, : Toxic-organic psychosis as a presenting feature in bacterial endocarditis. Mayo Clin Proc 30: 45–50, 1955.Google Scholar
  11. Ayd FJ: Cardiovascular effect of phenothiazines. Int Drug Ther Newsl 5: 1–8, 1970.Google Scholar
  12. Bank H: Idiopathic carotiditis. Lancet 1: 726, 1978.PubMedCrossRefGoogle Scholar
  13. Barlow JB, Pocock WA: The problem of nonejection systolic clicks and associated mitral systolic murmurs: Emphasis on the billowing mitral leaflet syndrome. Am Heart 190: 636–655, 1975.CrossRefGoogle Scholar
  14. Bellet S: Clinical Disorders of the Heart Beat. Philadelphia, Lea Febiger, 1971, p 658.Google Scholar
  15. Bernat JL, Sullivan JK: Trigeminal neuralgia from digitalis intoxication, lama 241: 164–165, 1979.Google Scholar
  16. Bigger JT, Kantor SJ, Glassman AH, : Cardiovascular effects of tricyclic antidepressant drugs, in Lipton MA, DiMascio A, Killam KF (eds): Psychopharmacology: A Generation of Progress. New York, Raven, 1978, pp 1033–1046.Google Scholar
  17. Boller F, Vrtunski PB, Mack JL, : Neuropsychological correlates of hypertension. Arch Neurol 34: 701–705, 1977.PubMedCrossRefGoogle Scholar
  18. Bulpitt CJ, Dollery CT: Side effects of hypotensive agents evaluated by a self-administered questionnaire. Br Med J 3: 485–490, 1973.PubMedCrossRefGoogle Scholar
  19. Byrd GJ: Lithium carbonate and methyldopa: Apparent interaction in man. Clin Toxicol 11: 1–4, 1977.PubMedCrossRefGoogle Scholar
  20. Chester EM, Agamanolis DP, Banker BQ : Hypertensive encephalopathy: A clinical pathologic study of 20 cases. Neurology 28: 928–939, 1978.PubMedCrossRefGoogle Scholar
  21. Cochran JW, Fox JH, Kelly MP: Reversible mental symptoms in temporal arteritis. J Nery Ment Dis 166: 446–447, 1978.CrossRefGoogle Scholar
  22. Corday E, Irving DW: Effect of cardiac arrhythmias on the cerebral circulation. Am J Cardiol 6: 803–808, 1960.PubMedCrossRefGoogle Scholar
  23. Corday E, Tzu-Wang L: Hemodynamic consequences of cardiac arrhythmias, in Hurst JW, Logue RB (eds): The Heart. New York, McGraw—Hill, 1970, pp 484–489.Google Scholar
  24. Crowe RR, Pauls DL, Venkatesh A, : Exercise and anxiety neurosis: Comparison of patients with and without mitral valve prolapse. Arch Gen Psychiatry 36: 652–653, 1979.Google Scholar
  25. Drake FR, Ebaugh FG: Pheochromocytoma and electroconvulsive therapy. Am J Psychiatry 113: 295–301, 1956.PubMedGoogle Scholar
  26. Dubach UC: Methyldopa and depression. Br Med J 1: 261–262, 1963.CrossRefGoogle Scholar
  27. Ebert MH, Shader RI: Cardiovascular effects, in Shader RI, DiMascio A (eds): Psychotropic Drug Side Effects. Baltimore, Williams Wilkins, 1970, pp 149–163.Google Scholar
  28. Eichna LW, Horvath SM, Bean WB: Postexertional orthostatic hypotension. Am J Med Sci 213: 641–654, 1947.PubMedCrossRefGoogle Scholar
  29. Endo M, Hirai K, O’Hara M: Paranoid-hallucinatory state induced in a depressive patient by methyldopa: A case report. Psychoneuroendocrinology 3: 211–215, 1978.PubMedCrossRefGoogle Scholar
  30. Ettlinger RE, Hunder GG, Ward LE: Polymyalgia rheumatica and giant cell arteritis. Ann Rev Med 29: 15–22, 1978.PubMedCrossRefGoogle Scholar
  31. Evans, DW, Lum LC: Hyperventilation: An important cause of pseudoangina. Lancet 1: 155–157, 1977.PubMedCrossRefGoogle Scholar
  32. Fairbairn JF, Clagett OT: Neurovascular compression syndromes of the thoracic outlet, in Fair-bairn JF, Juergens JL, Spittell JA (eds) Peripheral Vascular Diseases. Philadelphia, WB Saunders, 1972, pp 459–475.Google Scholar
  33. Falk RH, Nisbet PA, Gray TJ: Mental distress in patient on disopyramide. Lancet 1: 858–859, 1977.PubMedCrossRefGoogle Scholar
  34. Fetterman JL, Ashe WF: Cerebral debut of certain cases of cardiac disease. Ohio State Med J 34: 1354–1358, 1938.Google Scholar
  35. Finnerty FA: Hypertensive encephalopathy. Am Heart J 75: 559–563, 1968.PubMedCrossRefGoogle Scholar
  36. Fowler NO, McCall D, Chou T-C: Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs. Am J Cardiol 37: 223–230, 1976.PubMedCrossRefGoogle Scholar
  37. Freis ED: Thiazides and impotence. Drug Ther 8: 161, 1978.Google Scholar
  38. Frohlich ED, Tarazi RC, Dustan HP: Hyperdynamic beta-adrenergic circulatory state. Arch Int Med 123: 1–7, 1969.CrossRefGoogle Scholar
  39. Gaskell P: The importance of penile blood pressure in cases of impotence. Can Med Assoc J 105: 1047–1051, 1971.Google Scholar
  40. Gilbert GJ: Quinidine dementia. JAMA 237: 2093–2094, 1977.PubMedCrossRefGoogle Scholar
  41. Gill RJ: Essential hypertension (hypertensive vascular disease, hypertensive cardiovascular disease, primary hypertension), in Horwitz D. Magee JH (eds): Index of Suspicion in Treatable Diseases. Philadelphia, Lea Febiger, 1975, pp 439–447.Google Scholar
  42. Glassman, AH, Bigger JT, Kantor SJ, : Cardiovascular effects of imipramine. NCDEU Intercom 7: 8–12, 1978.Google Scholar
  43. Glassman AH, Bigger JT, Giardina EV, : Clinical characteristics of imipramine-induced orthostatic hypotension. Lancet 1: 468–472, 1979.PubMedCrossRefGoogle Scholar
  44. Goodwin FK, Ebert MH, Bunney WE: Mental effects of reserpine in man: A review, in Shader RI (eds): Psychiatric Complications of Medical Drugs. New York, Raven Press, 1972, pp 73–101.Google Scholar
  45. Green HL: Pheochromocytoma—a survey of current concepts. Henry Ford Hosp Med Bull 8: 103–115, 1960.PubMedGoogle Scholar
  46. Greenblatt DJ, Shader RI: Digitalis toxicity, in Shader RI (ed): Psychiatric Complications of Medical Drugs. New York, Raven Press, 1972, pp 25–47.Google Scholar
  47. Greenblatt DJ, Shader RI: Benzodiazepines in Clinical Practice. New York, Raven Press, 1974, pp 141–171.Google Scholar
  48. Greenwood WF: Profile of atrial myxoma. Am J Cardiol 21: 367–375, 1968.PubMedCrossRefGoogle Scholar
  49. Hamilton CR, Shelley WN, Tumulty PA: Giant cell arteritis: Including temporal arteritis and polymyalgia rheumatica. Medicine 50: 1–27, 1971.PubMedCrossRefGoogle Scholar
  50. Hart, CT: Formed visual hallucinations: A symptom of cranial arteritis. Br Med J 3: 643–644, 1967.PubMedCrossRefGoogle Scholar
  51. Hartshorn EA: Interactions of CNS drugs: Psychotherapeutic agents—The antipsychotic drugs. Drug Intel] and Clin Pharm 9: 536–550, 1975.Google Scholar
  52. Harvey WP- Clinical aspects of cardiac tumors. Am J Cardiol 21: 328–343, 1968.CrossRefGoogle Scholar
  53. Hurst JW, Logue RB: Etiology and clinical recognition of heart failure, in Hurst JW, Logue RB (eds): The Heart. New York, McGraw—Hill, 1970, pp 434–454.Google Scholar
  54. Hussar DA: Drug interactions. Am J Pharm 145: 65–116, 1973.PubMedGoogle Scholar
  55. Jefferson JW: Atypical manifestations of postural hypotension. Arch Gen Psychiatry 27: 250–251, 1972.PubMedCrossRefGoogle Scholar
  56. Jefferson JW: Beta-adrenergic receptor blocking drugs in psychiatry. Arch Gen Psychiatry 31: 681–691, 1974.PubMedCrossRefGoogle Scholar
  57. Jefferson JW: A review of the cardiovascular effects and toxicity of tricyclic antidepressants. Psychosom Med 37: 160–179, 1975.PubMedGoogle Scholar
  58. Jefferson JW: Use of beta-adrenergic blocking drugs in psychiatry, in Saxena PR. Forsyth RP (eds):Beta-Adrenoceptor Blocking Agents. Amsterdam, North—Holland Pub Co, 1976, pp 239–271.Google Scholar
  59. Jefferson JW, Greist JH: The cardiovascular effects and toxicity of lithium, in Davis JM. Greenblatt D (eds): Psychopharmacology Update: New and Neglected Areas. New York, Grune Stratton, 1979, pp 65–79.Google Scholar
  60. Knarr JW: Impotence from propranolol? Ann Int Med 85: 259, 1976.PubMedGoogle Scholar
  61. Kurtz JB: Methyldopa and forgetfulness. Lancet 1: 202–203, 1976.Google Scholar
  62. Lavin P, Alexander CP: Dementia associated with clonidine therapy. Br Med J 1: 628, 1975.PubMedCrossRefGoogle Scholar
  63. Lindberg BJ: Somatic complaints in the depressive symptomatology. Acta Psychiatr Scand 41: 419–427, 1965.PubMedCrossRefGoogle Scholar
  64. Litman GI, Friedman HM: Migraine and the mitral valve prolapse syndrome. Am Heart J 96: 610–614, 1978.PubMedCrossRefGoogle Scholar
  65. Logue RB, Hurst JW: Clinical recognition of coronary atherosclerotic heart disease and its complications, in Hurst JW, Logue RB (eds): The Heart. New York, McGraw—Hill, 1970, pp 946–984.Google Scholar
  66. Lovshin LL: Carotidynia. Headache 17: 192–195, 1977.PubMedCrossRefGoogle Scholar
  67. McAllen PM, Marshall J: Cardiac dysrhythmia and transient cerebral ischemic attacks. Lancet 1: 1212–1214, 1973.PubMedCrossRefGoogle Scholar
  68. McCrum ID, Guidry JR: Procainamide-induced psychosis. JAMA 240: 1265–1266, 1978.PubMedCrossRefGoogle Scholar
  69. McHaffie DJ, Guz A, Johnston A: Impotence in patient on disopyramide. Lancet 1: 859, 1977.PubMedCrossRefGoogle Scholar
  70. Magee JH: Vascular crises: Pheochromocytoma, in Horwitz O, Magee JH (eds): Index of Suspicion in Treatable Diseases. Philadelphia, Lea Febiger, 1975, pp 458–459.Google Scholar
  71. Manger WM, Gifford RW: Pheochromocytoma. New York, Springer—Verlag, 1977, pp 141–142.CrossRefGoogle Scholar
  72. Miller RA: Propranolol and impotence. Ann Int Med 85: 682–683, 1976.PubMedGoogle Scholar
  73. Mills LC: Drug-induced impotence. Am Fam Physician 12: 104–106, 1975.PubMedGoogle Scholar
  74. Moe GK, Abildskov JA: Antiarrhythmic drugs, in Goodman LS, Gilman A (eds): The Pharmacological Basis of Therapeutics. New York, MacMillan Publishing Co, 1975, pp 683–704.Google Scholar
  75. Mudd JW: Impotence responsive to glyceryl trinitrate. Am J Psychiatry 134: 922–925, 1977.Google Scholar
  76. Mumenthaler M: Giant cell arteritis (cranial arteritis, polymyalgia rheumatica). J Neurol 218: 219–236, 1978.PubMedCrossRefGoogle Scholar
  77. Murray TJ: Carotidynia: A cause of neck and face pain. Can Med Assoc J 120: 441–443, 1979.PubMedGoogle Scholar
  78. Naggar CZ: The mitral valve prolapse syndrome, spectrum and therapy. Med Clin North Am 63: 337–353, 1979.PubMedGoogle Scholar
  79. Newman RJ, Salerno HR: Sexual dysfunction due to methyldopa. Br Med J 4: 106, 1974.Google Scholar
  80. Nickerson M, Ruedy J: Antihypertensive agents and the drug therapy of hypertension, in Goodman LS, Gilman A (eds): The Pharmacological Basis of Therapeutics. New York, MacMillan, 1975, pp 705–726.Google Scholar
  81. Padfield PL, Smith DA, Fitzsimons EJ, : Disopyramide and acute psychosis. Lancet 1: 1152, 1977.PubMedCrossRefGoogle Scholar
  82. Pariente D: Methyldopa and depression. Br Med J 4: 110–111, 1973.PubMedCrossRefGoogle Scholar
  83. Pariser SF, Pinta ER, Jones BA: Mitral valve prolapse syndrome and anxiety neurosis/panic disorder. Am J Psychiatry 135: 246–247, 1978.PubMedGoogle Scholar
  84. Paulley JW, Hughes JP: Giant-cell arteritis or arteritis of the aged. Br Med J 2: 1562–1566, 1960.PubMedCrossRefGoogle Scholar
  85. Perley MJ,Guze SB: Hysteria—the stability and usefulness of clinical criteria. N Eng J Med 266: 421–426, 1962.CrossRefGoogle Scholar
  86. Pruitt AA, Rubin RH, Karchmer AW: Neurologic complications of bacterial endocarditis. Medicine 57: 329–343, 1978.PubMedCrossRefGoogle Scholar
  87. Ram CVS: Hypertensive encephalopathy, recognition and management. Arch Int Med 138: 1851–1853, 1978.CrossRefGoogle Scholar
  88. Reid JL, Dargie HJ, Davies DS, : Clonidine withdrawal in hypertension. Lancet 1: 1171–1174, 1977.PubMedCrossRefGoogle Scholar
  89. Rizzon P, Biasco G, Brindicci, G, : Familial syndrome of midsystolic click and late systolic murmur. Br Heart J 35: 245–259, 1973.PubMedCrossRefGoogle Scholar
  90. Schlant RC: Altered physiology of the cardiovascular system in heart failure, in Hurst JW, Logue RB (eds): The Heart. New York, McGraw–Hill, 1970, pp 405–423.Google Scholar
  91. Segraves RT: Pharmacological agents causing sexual dysfunction. J Sex Marital Ther 3: 157–176, 1977.CrossRefGoogle Scholar
  92. Shapiro W, Chawla N: Effects of pacing on cerebral blood flow and cardiac dynamics. Circulation (suppl 3 to Nos. 39–40 ): 184, 1969.Google Scholar
  93. Shear MK, Sacks MH: Digitalis delirium: Report of two cases. Am J Psychiatry 135: 109–110, 1978.PubMedGoogle Scholar
  94. Silverstein A: Neurological complications of anticoagulation therapy. Arch Int Med 139: 217–220, 1979.CrossRefGoogle Scholar
  95. Spiker DG, Weiss An, Chang SS, : Tricyclic antidepressant overdose: Clinical presentation and plasma levels. Clin Pharmacol Ther 18: 539–546, 1975.PubMedGoogle Scholar
  96. Spudis EV, Griffin A: Adams-Stokes attacks associated with hysteria. JAMA 229: 1636, 1974.PubMedCrossRefGoogle Scholar
  97. Stores G: Behavioral effects of anti-epileptic drugs. Dev Med Clin Neurol 17: 647–658, 1975.CrossRefGoogle Scholar
  98. Sulg IA, Cronqvist S, Schuller H, : The effect of intracardial pacemaker therapy on cerebral blood flow and electroencephalogram in patients with complete atrioventricular block. Circulation 39: 487–494, 1969.Google Scholar
  99. Swett, C, Cole JO, Hartz SC: Hypotension due to chlorpromazine. Arch Gen Psychiatry 34: 661–663, 1977.Google Scholar
  100. Thomas JE, Rooke ED, Kvale WF: The neurologists experience with pheochromocytoma. JAMA 197: 754–758, 1966.PubMedCrossRefGoogle Scholar
  101. Thornton WE: Dementia induced by methyldopa with haloperidol. N Eng J Med 294: 1222, 1976.CrossRefGoogle Scholar
  102. Venkatesh A, Pauls DL, Crowe R, : Mitral valve prolapse in anxiety neurosis. Clin Res 26: 656A, 1978.Google Scholar
  103. Vereker R: The psychiatric aspects of temporal arteritis. J Ment Sci 98: 280–286, 1952.PubMedGoogle Scholar
  104. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on mortality in hypertension: III. Influence of age, diastolic pressure, and prior car-diovascular disease; further analysis of side effects. Circulation 45: 991–1004, 1972.Google Scholar
  105. Walter PF, Crawley IS, Dorney ER: Carotid sinus hypersensitivity and syncope. Am J Cardiol 42: 396–402, 1978.PubMedCrossRefGoogle Scholar
  106. Weiss S, Ferris EB: Adams-Stokes syndrome with transient complete heart block of vasovagal reflex origin. Arch Int Med 54: 931–951, 1934.CrossRefGoogle Scholar
  107. Wenger NK: Tumors of the heart, in Hurst JW, Logue RB (eds): The Heart. New York, McGraw–Hill, 1970, pp 1275–1290.Google Scholar
  108. Wharton RN: Atrial myxoma masquerade. Am J Psychiatry 134: 1441–1442, 1977.PubMedGoogle Scholar
  109. Whitlock FA, Evans LEJ: Drugs and depression. Drugs 15: 53–71, 1978.PubMedCrossRefGoogle Scholar
  110. Williams LC, Turney JH, Parsons V: Beta-blocker withdrawal syndrome. Lancet 1: 494–495, 1979.PubMedCrossRefGoogle Scholar
  111. Wooley CF: Where are the diseases of yesteryear? Circulation 53: 749–751, 1976.PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1981

Authors and Affiliations

  • James W. Jefferson
    • 1
  • John R. Marshall
    • 1
  1. 1.University of Wisconsin Medical SchoolMadisonUSA

Personalised recommendations